An Achilles heel of AML
April 15, 2012
The key to treating one of the most common types of human leukemia may lie within mutations in a gene called FLT3, according to new research led by physician-scientists at the University of California, San Francisco Helen Diller Family Comprehensive Cancer Center.
Read more
Reading level: College
EurekAlert!, the online, global news service operated by AAAS, the science society




